The recombinant protein is typically expressed in E. coli systems, with purification involving affinity chromatography (e.g., His-tagged variants) . While tag specifications may vary during production , purity is confirmed via SDS-PAGE (>90%) . Storage conditions include:
| Property | Detail | Source |
|---|---|---|
| Molecular Weight | ~8.9 kDa | |
| Localization | Mitochondrial membrane (inner membrane) | |
| Expression System | E. coli | |
| Purity | >90% (SDS-PAGE) |
Romo1 facilitates mitochondrial ROS production through mechanisms involving:
Mitochondrial membrane channels: Regulates ion flux and ROS generation .
Redox sensing: Acts as a sensor for oxidative stress, linking ROS levels to cellular responses .
Apoptosis signaling: Mediates ROS-dependent apoptosis in response to TNF-α or oxidative damage .
In Xenopus laevis, romo1 exhibits tissue-specific expression:
Photoreceptors: Expressed exclusively in rod outer segments, localizing to disk rims and incisures .
Cones: Absent in cones, contrasting with prph2 (a related protein expressed in cones) .
| Tissue | Expression | Localization | Source |
|---|---|---|---|
| Rod Photoreceptors | High | Disk rims and incisures | |
| Cones | Absent | Not detected |
Recombinant romo1 is utilized in:
ROS detection assays: ELISA or fluorescence-based methods to quantify ROS levels .
Mitochondrial function studies: Investigating ROS-dependent apoptosis or bioenergetics .
Photoreceptor biology: Exploring romo1’s role in rod-specific ROS regulation and retinal degeneration models .
Gene knockout studies: Deletion of romo1 in Xenopus did not disrupt rod outer segment morphology, suggesting functional redundancy with prph2 .
Cancer research parallels: While human romo1 overexpression correlates with poor prognosis in glioblastoma and NSCLC , Xenopus studies focus on developmental and photoreceptor contexts .
While Xenopus romo1 shares structural homology with human romo1 (e.g., mitochondrial localization and ROS modulation) , functional differences emerge:
Expression breadth: Human romo1 is linked to cancer progression via immune suppression and ROS-driven apoptosis , whereas Xenopus romo1 shows restricted photoreceptor expression .
Therapeutic implications: Human romo1 inhibition enhances immunotherapy efficacy in glioblastoma , while Xenopus studies emphasize developmental roles .
KEGG: xla:734542
UniGene: Xl.77381
Romo1 (Reactive oxygen species modulator 1) is a nuclear-encoded mitochondrial inner membrane protein that regulates ROS production and serves as an essential redox sensor in mitochondrial dynamics. In Xenopus laevis, Romo1 (UniProt: Q4V7T9) contains 79 amino acids with a sequence: MPVAVGPYGQSQPNCFDRVKMGFMMGFAVGMAAGALFGTFSCLRFGMRGRELMGGVGKTMMQSGGTFGTFMAIGMGIRC .
Structurally, Romo1 possesses two transmembrane domains (TMDs), each consisting of an α-helix connected by a basic loop. While TMD1 contains a hydrophobic α-helix, TMD2 forms a distinctive amphipathic helix with polar amino acids clustered on one surface. This structural arrangement is highly conserved across eukaryotes and appears critical for its function as an ion channel .
Romo1 functions as a nonselective cation channel with unique viroporin-like characteristics, distinguishing it from other known eukaryotic ion channels. The protein forms a channel using its amphipathic helical transmembrane domain, which is necessary for its pore-forming activity. Notably, Romo1's channel activity is specifically inhibited by Fe²⁺ ions, which are essential transition metal ions in ROS metabolism .
Methodologically, this channel activity can be confirmed through planar bilayer patch clamp assays using synthesized Romo1. Due to its tendency to aggregate in salt solutions, special targeting methods have been developed to maximize targeting efficiency in bilayer systems, such as using sorbitol solutions for effective protein delivery to preformed planar bilayers .
Several techniques can be employed to measure ROS in Xenopus models:
DCFDA Fluorescent Dye: This cell-permeable dye is widely used for ROS detection in cultured cells and has been optimized for monitoring ROS levels in fresh and bench-aged Xenopus oocytes and eggs .
HyPer Transgenic Reporter System: This genetic sensor is specifically sensitive to hydrogen peroxide (H₂O₂). The HyPer system consists of a prokaryotic OxyR domain that undergoes reversible conformational changes when oxidized, which can be detected through two excitations of fluorescence. By calculating the ratio of HyPer-oxidised and HyPer-reduced signals, researchers can monitor H₂O₂ levels in vivo throughout development .
Antioxidant Treatment Controls: N-acetyl-cysteine (NAC) and MCI-186 (Edavarone) can be used as experimental controls to reduce oxidative stress. NAC acts as a precursor of glutathione, while MCI-186 functions as a hydroxyl radical scavenger .
Romo1 is remarkably conserved across eukaryotes, with its amino acid sequence being 100% identical among 82 of 247 animal species compared to human Romo1 . This high conservation suggests fundamental importance in cellular function.
In mammals, Romo1 knockout studies show that it is essential for embryonic development, with null mice dying before embryonic day 8.5, even earlier than knockouts of mitochondrial fusion proteins like OPA1 or MFN1/2 . Similarly, in Xenopus, ROS signaling (which Romo1 modulates) plays critical roles in early embryonic development, particularly in mesoderm formation .
When using Xenopus as a model system for Romo1 research, researchers should consider:
Developmental Timing: Xenopus embryos display elevated and sustained ROS levels throughout early development until neurula stages, after which levels decrease to less than half the initial ROS levels by tadpole stage .
Tissue-Specific Differences: The major source of ROS in Xenopus oocytes and eggs appears to be plasma membrane NADPH oxidase, with mitochondrial generation contributing to a lesser extent , which may differ from mammalian systems where mitochondrial ROS often predominates.
Experimental Accessibility: The Xenopus model offers advantages for studying ROS dynamics in vivo due to the accessibility of embryos for manipulation and observation, enabling visualization of ROS throughout development using transgenic reporters .
To investigate Romo1's role in mitochondrial dynamics in Xenopus systems, researchers can employ several approaches:
Differentiating between direct and indirect effects of Romo1 on ROS production requires multi-faceted experimental approaches:
Temporal Manipulation: Employ inducible expression or inhibition systems to temporally control Romo1 activity, allowing observation of immediate (likely direct) versus delayed (potentially indirect) effects on ROS levels.
Domain-Specific Mutations: Introduce mutations in specific domains of Romo1, particularly in the amphipathic helical transmembrane domain necessary for channel activity, to dissect structure-function relationships. This approach can help determine which aspects of ROS modulation are dependent on the ion channel function versus other potential protein-protein interactions .
Isolated System Assays: Reconstitute purified Romo1 in liposomes or planar lipid bilayers to assess its direct effects on membrane permeability and ion flux in the absence of other cellular components .
Inhibitor Studies: Use Fe²⁺ ions, which specifically inhibit Romo1 channel activity, as a tool to acutely block function and observe immediate effects on ROS production .
Epistasis Experiments: Combine Romo1 manipulation with alterations in known ROS-producing (e.g., NADPH oxidase) or ROS-scavenging (e.g., superoxide dismutase) systems to establish hierarchy and interdependence in ROS regulatory pathways.
Optimal expression and purification of recombinant Xenopus laevis Romo1 requires careful consideration of its membrane protein nature:
Expression System Selection: For a small membrane protein like Romo1, bacterial systems (specifically E. coli) with specialized vectors containing fusion tags (such as His6, GST, or MBP) can be effective. Alternatively, insect cell expression systems may provide better folding for functional studies.
Buffer Optimization: Due to Romo1's tendency to aggregate in salt-containing buffers, consider using non-ionic osmolytes like sorbitol (1M) during purification steps .
Storage Conditions: Store purified Romo1 in Tris-based buffer with 50% glycerol at -20°C for short-term storage or at -80°C for extended storage. Avoid repeated freeze-thaw cycles which can compromise protein integrity .
Functional Validation: After purification, validate protein activity through bilayer patch clamp experiments or ROS production assays in reconstituted systems before proceeding to more complex functional studies .
Quality Control Measures: Confirm protein identity and integrity using mass spectrometry, circular dichroism to assess secondary structure content, and Western blotting with Romo1-specific antibodies.
To effectively study Romo1-ROS relationships during Xenopus development:
Temporal Profiling: Use the HyPer transgenic reporter system to establish a detailed temporal profile of H₂O₂ levels throughout development, from unfertilized eggs through tadpole stages, as a baseline for understanding normal ROS dynamics .
Stage-Specific Manipulations: Employ techniques for stage-specific modulation of Romo1 expression or activity:
Microinjection of mRNAs encoding wild-type or mutant Romo1 forms at specific developmental stages
CRISPR/Cas9-mediated genome editing to generate Romo1 knockout or knock-in lines
Pharmacological approaches using specific inhibitors of Romo1 channel activity
Functional Readouts: Assess developmental consequences through:
Rescue Experiments: Design rescue experiments by co-expressing Romo1 with antioxidants or by modulating specific downstream pathways to establish causality in observed phenotypes.
The table below summarizes the relationship between ROS levels and developmental stages in Xenopus embryos:
| Developmental Stage | Relative H₂O₂ Level | Romo1 Significance |
|---|---|---|
| Unfertilized egg | Baseline | Maternal Romo1 present |
| Fertilization | Sharp increase | Oxidative burst initiation |
| Cleavage to Blastula | Elevated | Sustained high levels |
| Gastrula | Elevated | Critical for mesoderm formation |
| Neurula | Beginning to decrease | Transition period |
| Tadpole | Low (<50% of initial) | Reduced requirement |
When investigating Romo1's ion channel properties across species, researchers should consider:
Comparative Sequence Analysis: Although highly conserved, subtle sequence variations between Xenopus and mammalian Romo1 might affect channel properties. Perform detailed sequence alignments focusing on the amphipathic helical transmembrane domain critical for channel formation .
Expression System Selection: For direct comparisons:
Use identical expression systems for both proteins
Consider heterologous expression in Xenopus oocytes, which provides a native-like membrane environment for frog proteins
Alternative mammalian cell lines (HEK293, CHO) with controlled expression levels
Electrophysiological Approaches:
Channel Modulation Comparison:
Test sensitivity to Fe²⁺ inhibition across species
Examine responses to physiological modulators like oxidative stress
Assess voltage dependence and ion selectivity properties
Functional Consequences:
Compare effects on mitochondrial membrane potential
Assess ROS production in response to channel activity
Evaluate mitochondrial morphology changes upon activation/inhibition
Common challenges in Romo1 expression and their solutions include:
Protein Aggregation: Romo1 tends to aggregate when expressed recombinantly.
Low Expression Yields: As a small membrane protein, Romo1 may have low expression yields.
Solution: Optimize codon usage for the expression system being used.
Solution: Use specialized bacterial strains designed for membrane protein expression (e.g., C41(DE3), C43(DE3)).
Solution: Test different induction conditions (temperature, inducer concentration, duration).
Improper Folding: Ensuring proper folding of the transmembrane domains.
Solution: Express at lower temperatures (16-20°C) to slow folding and prevent aggregation.
Solution: Include appropriate detergents or lipids during extraction and purification.
Functional Validation: Confirming that recombinant Romo1 retains native activity.
Solution: Establish robust functional assays such as ion channel measurements in reconstituted systems.
Solution: Compare activity parameters with native Romo1 where possible.
To distinguish Romo1-dependent from Romo1-independent ROS production:
Genetic Approaches:
Generate Romo1 knockdown or knockout models using morpholinos or CRISPR/Cas9
Create rescue lines expressing wild-type or mutant versions of Romo1
Employ inducible expression systems to temporally control Romo1 levels
Pharmacological Approaches:
Compartment-Specific Detection:
Employ subcellular-targeted ROS sensors (mitochondrial, cytosolic, membrane-associated)
Use organelle-specific dyes in combination with ROS indicators
Biochemical Source Analysis:
Isolate subcellular fractions (mitochondria, plasma membrane, endoplasmic reticulum)
Measure ROS production capacity in each fraction with and without Romo1 inhibition
Reconstitute purified components to assess direct contributions
Kinetic Analysis:
Perform time-course studies following Romo1 manipulation
Immediate changes likely reflect direct effects, while delayed responses may indicate secondary mechanisms
Advanced imaging techniques for studying Romo1 in Xenopus embryos include:
Super-Resolution Microscopy:
Stimulated Emission Depletion (STED) microscopy for visualizing Romo1 distribution within mitochondrial subcompartments
Single-molecule localization microscopy (PALM/STORM) to determine precise protein organization
Expansion microscopy to physically enlarge specimens for improved resolution
Live Imaging Applications:
Light sheet microscopy for long-term, low-phototoxicity imaging of developing embryos
Multiphoton microscopy for deeper tissue penetration in later stage embryos
Fluorescence lifetime imaging (FLIM) to detect changes in the microenvironment around Romo1
Functional Imaging Approaches:
Sample Preparation Considerations:
Optimized fixation protocols that preserve mitochondrial morphology
Clearing techniques for improved optical access to deep tissues
Cryosectioning approaches for high-resolution analysis of specific regions
Quantitative Analysis Methods:
Automated image analysis pipelines for mitochondrial morphology quantification
Correlation analysis between Romo1 levels, localization, and ROS production
Machine learning approaches for complex pattern recognition in subcellular distribution
When facing contradictory ROS data related to Romo1 across different contexts:
The dual functionality of Romo1 as both an ion channel and ROS modulator has significant implications:
Precision Targeting Opportunities: The unique viroporin-like structure of Romo1 distinguishes it from other eukaryotic ion channels, potentially allowing for highly specific therapeutic targeting with minimal off-target effects .
Mitochondrial Medicine Applications: Given Romo1's essential role in:
Therapeutics modulating Romo1 could potentially address mitochondrial disorders, metabolic diseases, and developmental abnormalities.
ROS-Related Conditions: Conditions characterized by oxidative stress imbalance could benefit from Romo1-targeted approaches:
Neurodegenerative diseases
Ischemia-reperfusion injury
Aging-related degeneration
Mechanism-Based Drug Design Strategy:
Predictive Biomarkers: Romo1 status (expression level, activity) could serve as a biomarker for:
The high evolutionary conservation of Romo1 across eukaryotes provides valuable insights for research:
Model System Selection: The 100% sequence identity of Romo1 among numerous animal species suggests findings from one model organism may translate well to others. Researchers can strategically select models based on experimental advantages rather than concerns about protein divergence:
Xenopus for developmental studies and accessible embryology
Mammals for metabolic and physiological relevance to humans
Yeast for high-throughput genetic screens
Functional Domain Analysis: The conservation pattern within Romo1 highlights critical functional regions:
Experimental Validation Across Species:
Confirm key findings in multiple model systems to establish universal principles
Investigate any species-specific differences as potentially informative adaptations
Use evolutionary conservation patterns to guide mutagenesis studies (focus on conserved residues)
Data Interpretation Framework:
Core functions (ion channel activity, ROS modulation) likely conserved across species
Regulatory mechanisms and contextual roles may show more species-specific variation
When contradictions arise between models, focus on environmental or physiological differences rather than assuming protein functional differences
Translational Research Potential:
High conservation suggests Xenopus findings may have direct relevance for human health applications
Therapeutic approaches targeting conserved domains likely to have cross-species efficacy
Evolutionary medicine perspective may reveal why such conservation exists (fundamental cellular necessity)